Modelling chemotherapeutic damage to mesenchymal stem cells

May, Jennifer E.; Xu, Jinsheng; Morse, Ruth; Avent, Neil D.; Cox, Christine; Wexler, Sarah A.; Donaldson, Craig

All Outputs (3)

Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy (2010)
Journal Article
Hows, J., Wexler, S., Kemp, K. C., Morse, R., Wexler, S. A., Cox, C., …Donaldson, C. (2010). Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Annals of Hematology, 89(7), 701-713. https://doi.org/10.1007/s00277-009-0896-2

Hematopoietic recovery after high-dose chemotherapy (HDC) in the treatment of hematological diseases may be slow and/or incomplete. This is generally attributed to progressive hematopoietic stem cell failure, although defective hematopoiesis may be i... Read More about Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.

An in vitro model of chemotherapeutic damage to mesenchymal stem cells (2010)
Presentation / Conference
May, J. E., Xu, J., Morse, R., Avent, N. D., Cox, C., Wexler, S. A., & Donaldson, C. (2010, April). An in vitro model of chemotherapeutic damage to mesenchymal stem cells. Poster presented at 4th UK Mesenchymal Stem Cell Meeting, Leeds University, UK

Modelling chemotherapeutic damage to mesenchymal stem cells (2010)
Journal Article
May, J. E., Xu, J., Morse, R., Avent, N. D., Cox, C., Wexler, S. A., & Donaldson, C. (2010). Modelling chemotherapeutic damage to mesenchymal stem cells. Haematologica, 95(Supp 2), 664